Concepedia

Julie Byrne

JB

12

Publications

1.1K

Citations

11

H-Index

2004

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Mayo Clinic in Florida

Winship Cancer Institute

The University of Texas MD Anderson Cancer Center

Providence College

Julie Byrne is an author at GlaxoSmithKline (United States) specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

2004–2021

12

Publications

12

Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials

Edith A. Perez, María Koehler, Julie Byrne et al. · Mayo Clinic Proceedings · 2008 · 315 citations

, , +8

Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials

Edith A. Perez, María Koehler, Julie Byrne et al. · Mayo Clinic Proceedings · 2008 · 297 citations

, , +8

Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

Asim V. Farooq, Simona Degli Esposti, Rakesh Popat et al. · Ophthalmology and Therapy · 2020 · 169 citations · Full text

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

John Crown, H. A. Burris, Frances M. Boyle et al. · Breast Cancer Research and Treatment · 2008 · 97 citations

, , +8

Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM)

Sagar Lonial, Ajay K. Nooka, Praneetha Thulasi et al. · Blood Cancer Journal · 2021 · 83 citations · Full text

Rows per page

1–5 of 12